Adeshwar Meditex Ltd
Incorporated in 2007, Adeshwar Meditex Ltd is a manufacturer and exporter of all forms of first aid kits, surgical dressing, surgical plastics and other medical disposables[1]
- Market Cap ₹ 40.0 Cr.
- Current Price ₹ 27.7
- High / Low ₹ 36.0 / 0.00
- Stock P/E 23.2
- Book Value ₹ 23.3
- Dividend Yield 0.00 %
- ROCE 9.99 %
- ROE 6.48 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 1.19 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 7.04% over past five years.
- Company has a low return on equity of 5.99% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|
58.60 | 52.92 | 56.12 | 65.97 | 64.76 | 82.36 | 82.56 | |
52.96 | 47.44 | 50.64 | 61.22 | 61.39 | 77.18 | 77.89 | |
Operating Profit | 5.64 | 5.48 | 5.48 | 4.75 | 3.37 | 5.18 | 4.67 |
OPM % | 9.62% | 10.36% | 9.76% | 7.20% | 5.20% | 6.29% | 5.66% |
0.10 | 0.25 | 0.28 | 0.13 | 0.23 | 0.31 | 0.30 | |
Interest | 1.78 | 2.23 | 2.52 | 2.19 | 2.03 | 2.05 | 2.04 |
Depreciation | 0.36 | 0.35 | 0.34 | 0.35 | 0.38 | 0.53 | 0.56 |
Profit before tax | 3.60 | 3.15 | 2.90 | 2.34 | 1.19 | 2.91 | 2.37 |
Tax % | 29.72% | 28.25% | 27.24% | 28.63% | 33.61% | 28.52% | |
2.54 | 2.26 | 2.12 | 1.68 | 0.79 | 2.07 | 1.72 | |
EPS in Rs | 5.10 | 4.54 | 4.03 | 1.60 | 0.55 | 1.43 | 1.20 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 7% |
3 Years: | 14% |
TTM: | 2% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -4% |
3 Years: | -1% |
TTM: | 43% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 13% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | 6% |
Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|
Equity Capital | 4.98 | 4.98 | 5.27 | 10.53 | 14.43 | 14.43 | 14.43 |
Reserves | 8.55 | 10.81 | 13.64 | 10.05 | 16.52 | 18.48 | 19.21 |
11.58 | 19.92 | 21.32 | 22.45 | 18.99 | 16.43 | 13.50 | |
7.33 | 5.79 | 14.57 | 19.27 | 22.63 | 17.67 | 24.29 | |
Total Liabilities | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 71.43 |
2.36 | 2.44 | 2.28 | 2.24 | 3.03 | 3.70 | 3.77 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.02 | 0.04 | 0.08 | 0.08 | 0.10 | 0.10 | 0.10 |
30.06 | 39.02 | 52.44 | 59.98 | 69.44 | 63.21 | 67.56 | |
Total Assets | 32.44 | 41.50 | 54.80 | 62.30 | 72.57 | 67.01 | 71.43 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
-0.99 | 3.15 | -2.44 | 5.93 | |||
1.58 | -0.71 | -1.16 | -1.16 | |||
-0.07 | -3.11 | 4.44 | -4.78 | |||
Net Cash Flow | 0.53 | -0.66 | 0.85 | -0.02 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|
Debtor Days | 108.69 | 134.63 | 181.26 | 150.82 | 183.06 | 123.78 |
Inventory Days | 64.44 | 112.51 | 119.36 | 174.35 | 168.24 | 127.72 |
Days Payable | 43.11 | 38.76 | 104.70 | 119.86 | 138.51 | 88.18 |
Cash Conversion Cycle | 130.02 | 208.39 | 195.93 | 205.31 | 212.79 | 163.33 |
Working Capital Days | 129.43 | 211.19 | 222.82 | 194.70 | 221.28 | 170.71 |
ROCE % | 17.69% | 14.27% | 11.22% | 6.93% | 9.99% |
Documents
Announcements
-
Post-Offer Advertisement
1h - Kunvarji Finstock Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer Advertisement under Regulation 18(12) in terms of SEBI (Substantial …
- Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations, 2015 For The Financial Year Ended 31St March 2024 1d
- Statement Of Investor Complaints Under Regulation 13(3) Of SEBI (LODR) Regulations, 2015. 20 Apr
- Disclosure Under Reg 40(9) Of SEBI (LODR) Regulations, 2015 19 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
12 Apr - Disclosure under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Business Overview:[1][2]
Company is a WHO cGMP, CE, ISO 9001-2008 Certified manufacturer and exporter of sterile surgical wound dressing products and medical disposables. It deals in all kinds of surgical, pharmaceutical, medicine items including first aid kits, surgical dressings including sterile medicated wound dressings, sterile advanced hemostatic dressings, chitosan, oxidized cellulose and gelatin sponges, medical bandages, medical kits, Home Based New Born (HBNC) and other kits, face masks, and dealing in various items and Turnkey projects for all of the above products and other ancillary business